Abstract
AIMS: To examine neuroendocrine differentiation, as shown by chromogranin A (CGA) expression, in cervical carcinomas. METHODS: Sixty seven cervical carcinomas were studied and were classified as adenocarcinomas, adenosquamous carcinomas or squamous cell carcinomas based on the assessment of haematoxylin and eosin staining and stains for mucin. Where features of glandular differentiation were identified, sections were also stained for evidence of intestinal type mucin. CGA immunostaining was done and the results were graded on a three point scale: 0, + (1-5% of cells positive) and ++ (> 5% of cells positive). These findings were then analysed with respect to lymph node status, tumour differentiation and clinical outcome. RESULTS: There were 32 adenocarcinomas, 18 adenosquamous carcinomas and 17 squamous cell carcinomas. Positive staining was seen in 14 (20.9%) cases, of which four were strongly positive. All but one case were either adenocarcinomas or adenosquamous carcinomas. There was a trend for CGA positivity to be related to intestinal differentiation but this failed to reach statistical significance. No correlation could be demonstrated between CGA staining and lymph node status, tumour differentiation and clinical outcome. CONCLUSIONS: Neuroendocrine differentiation is common in cervical carcinomas where there is evidence of glandular differentiation. Whilst the numbers in this study are relatively small, the presence of neuroendocrine cells in otherwise typical carcinomas does not seem to have any association with clinical behaviour.
Full text
PDF


Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barrett R. J., 2nd, Davos I., Leuchter R. S., Lagasse L. D. Neuroendocrine features in poorly differentiated and undifferentiated carcinomas of the cervix. Cancer. 1987 Nov 1;60(9):2325–2330. doi: 10.1002/1097-0142(19871101)60:9<2325::aid-cncr2820600935>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
- Cheng H., Leblond C. P. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types. Am J Anat. 1974 Dec;141(4):537–561. doi: 10.1002/aja.1001410407. [DOI] [PubMed] [Google Scholar]
- FOX H., KAZZAZ B., LANGLEY F. A. ARGYROPHIL AND ARGENTAFFIN CELLS IN THE FEMALE GENITAL TRACT AND IN OVARIAN MUCINOUS CYSTS. J Pathol Bacteriol. 1964 Oct;88:479–488. doi: 10.1002/path.1700880211. [DOI] [PubMed] [Google Scholar]
- Fetissof F., Dubois M. P., Heitz P. U., Lansac J., Arbeille-Brassart B., Jobard P. Endocrine cells in the female genital tract. Int J Gynecol Pathol. 1986;5(1):75–87. doi: 10.1097/00004347-198603000-00009. [DOI] [PubMed] [Google Scholar]
- Hamada Y., Oishi A., Shoji T., Takada H., Yamamura M., Hioki K., Yamamoto M. Endocrine cells and prognosis in patients with colorectal carcinoma. Cancer. 1992 Jun 1;69(11):2641–2646. doi: 10.1002/1097-0142(19920601)69:11<2641::aid-cncr2820691104>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
- Inoue M., Delellis R. A., Scully R. E. Immunohistochemical demonstration of chromogranin in endometrial carcinomas with argyrophil cells. Hum Pathol. 1986 Aug;17(8):841–847. doi: 10.1016/s0046-8177(86)80205-2. [DOI] [PubMed] [Google Scholar]
- Inoue M., Ueda G., Nakajima T. Immunohistochemical demonstration of neuron-specific enolase in gynecologic malignant tumors. Cancer. 1985 Apr 15;55(8):1686–1690. doi: 10.1002/1097-0142(19850415)55:8<1686::aid-cncr2820550813>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
- Lloyd R. V., Mervak T., Schmidt K., Warner T. F., Wilson B. S. Immunohistochemical detection of chromogranin and neuron-specific enolase in pancreatic endocrine neoplasms. Am J Surg Pathol. 1984 Aug;8(8):607–614. doi: 10.1097/00000478-198408000-00004. [DOI] [PubMed] [Google Scholar]
- O'Hanlan K. A., Goldberg G. L., Jones J. G., Runowicz C. D., Ehrlich L., Rodriguez-Rodriguez L. Adjuvant therapy for neuroendocrine small cell carcinoma of the cervix: review of the literature. Gynecol Oncol. 1991 Nov;43(2):167–172. doi: 10.1016/0090-8258(91)90066-e. [DOI] [PubMed] [Google Scholar]
- Piehl M. R., Gould V. E., Warren W. H., Lee I., Radosevich J. A., Ma Y. X., Rosen S. T. Immunohistochemical identification of exocrine and neuroendocrine subsets of large cell lung carcinomas. Pathol Res Pract. 1988 Nov;183(6):675–682. doi: 10.1016/s0344-0338(88)80052-9. [DOI] [PubMed] [Google Scholar]
- Savargaonkar P. R., Hale R. J., Pope R., Fox H., Buckley C. H. Enteric differentiation in cervical adenocarcinomas and its prognostic significance. Histopathology. 1993 Sep;23(3):275–277. doi: 10.1111/j.1365-2559.1993.tb01201.x. [DOI] [PubMed] [Google Scholar]
- Sidhu G. S. The endodermal origin of digestive and respiratory tract APUD cells. Histopathologic evidence and a review of the literature. Am J Pathol. 1979 Jul;96(1):5–20. [PMC free article] [PubMed] [Google Scholar]
- Stahl R., Demopoulos R. I., Bigelow B. Carcinoid tumor within a squamous cell carcinoma of the cervix. Gynecol Oncol. 1981 Jun;11(3):387–392. doi: 10.1016/0090-8258(81)90054-8. [DOI] [PubMed] [Google Scholar]
- Tateishi R., Wada A., Hayakawa K., Hongo J., Ishii S. Argyrophil cell carcinomas (apudomas) of the uterine cervix. Light and electron microscopic observations of 5 cases. Virchows Arch A Pathol Anat Histol. 1975;366(4):257–274. doi: 10.1007/BF00433887. [DOI] [PubMed] [Google Scholar]
- Ueda G., Nishino T., Saito J., Abe Y., Shimizu H., Tanizawa O. Detection of chromogranin in argyrophil cells of endometrial carcinoma. Gynecol Oncol. 1987 Jun;27(2):159–165. doi: 10.1016/0090-8258(87)90288-5. [DOI] [PubMed] [Google Scholar]
- Ueda G., Shimizu C., Shimizu H., Saito J., Tanaka Y., Inoue M., Tanizawa O. An immunohistochemical study of small-cell and poorly differentiated carcinomas of the cervix using neuroendocrine markers. Gynecol Oncol. 1989 Aug;34(2):164–169. doi: 10.1016/0090-8258(89)90134-0. [DOI] [PubMed] [Google Scholar]
- Ueda G., Yamasaki M. Neuroendocrine carcinoma of the uterus. Curr Top Pathol. 1992;85:309–335. doi: 10.1007/978-3-642-75941-3_10. [DOI] [PubMed] [Google Scholar]

